Literature DB >> 3943014

Primary breast cancer. Flow cytometric DNA pattern in relation to clinical and histopathologic characteristics.

E Thorud, S D Fosså, S Vaage, O Kaalhus, O S Knudsen, O Børmer, M C Shoaib.   

Abstract

Cell suspensions of 59 primary operable mammary carcinomas in women were subjected to flow cytometric DNA analyses. The results were correlated to histopathological grading, clinical staging, menopausal status and estrogen receptor status. Thirty-two tumors showed a DNA peak above +25% of murine lymphocyte level and were named distinct aneuploid (AN). Twenty-seven tumors did not show such a peak and were named near diploid (ND). Low histopathological malignancy grade was associated with a high frequency of ND tumors (P less than 0.05). Small tumors (T1) were predominantly ND (14/19), while larger tumors (T2-3) showed a high frequency of AN tumors (27/40) (P less than 0.01). Tumors occurring in post-menopausal women were often AN, while those arising in premenopausal women were frequently ND (P less than 0.06). No clear correlation was found between the DNA ploidy pattern and estrogen receptor status. There was a tendency that patients with AN tumors had a higher frequency of relapses during the first 4-5 years of follow-up than those with ND breast carcinomas.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3943014     DOI: 10.1002/1097-0142(19860215)57:4<808::aid-cncr2820570421>3.0.co;2-#

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  17 in total

1.  Flow Cytometric Analysis to Assess the Malignant Potential of Phyllodes Tumor.

Authors: 
Journal:  Breast Cancer       Date:  1994-12-30       Impact factor: 4.239

2.  Has adjuvant treatment of breast cancer had an unfair trial?

Authors:  I Mittra
Journal:  BMJ       Date:  1990-12-08

Review 3.  Review: assessment of cell proliferation in histological material.

Authors:  P A Hall; D A Levison
Journal:  J Clin Pathol       Date:  1990-03       Impact factor: 3.411

4.  DNA ploidy level and S-phase fraction as prognostic factors in breast cancer.

Authors:  T Yokoe; M Izuo; T Ishida; Y Iino; T Kawai
Journal:  Jpn J Surg       Date:  1990-09

5.  Prognostic value of nuclear DNA content in breast cancer in relation to tumor size, nodal status, and estrogen receptor content.

Authors:  A von Rosen; L E Rutqvist; J Carstensen; A Fallenius; L Skoog; G Auer
Journal:  Breast Cancer Res Treat       Date:  1989-01       Impact factor: 4.872

6.  An immunohistological study of breast cancer--with special reference to the expression of carbohydrate antigens and estrogen receptor status.

Authors:  M Sowa; Y S Chung; Y Kato; M Nishimura; T Kubo; H Maekawa; Y Fujimoto; K Umeyama; M Kawahara
Journal:  Jpn J Surg       Date:  1990-05

7.  Proliferating cell nuclear antigen in breast lesions: correlation of c-erbB-2 oncoprotein and EGF receptor and its clinicopathological significance in breast cancer.

Authors:  P Shrestha; K Yamada; T Wada; S Maeda; M Watatani; M Yasutomi; H Takagi; M Mori
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

8.  DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients.

Authors:  C R Wenger; S Beardslee; M A Owens; G Pounds; T Oldaker; P Vendely; M R Pandian; D Harrington; G M Clark; W L McGuire
Journal:  Breast Cancer Res Treat       Date:  1993-10       Impact factor: 4.872

9.  Nuclear DNA content in breast carcinoma with special reference to the parameters of malignant potentiality.

Authors:  S Suehiro; Y Hamada; M Toi; T Nakamura; M Niimoto; T Hattori
Journal:  Jpn J Surg       Date:  1990-01

10.  Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry.

Authors:  A E Dawson; J A Norton; D S Weinberg
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.